The family of Henrietta Lacks is suing rare disease drug developer Ultragenyx over its use of technology built from her cells, which were taken without her knowledge or consent in 1951 and immortalized into a cell line that’s been widely used in biomedical research since.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,